The European Commission’s work to secure access to potential COVID-19 vaccines is welcome, but other therapies are needed to end the pandemic and negotiations with European manufacturers of anti-viral antibodies should not be further delayed
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.